Search results for: 'oncology care t 2016 45 phase ii orr licens'
- Did you mean
- oncology case t 2016 45 phase ii our licens
- Related search terms
- Licensing Terms & Agreements In Pharma, Biotech and Diagnostics
- licensing texas and agreements in pharma biotech and diagnostics
- licensing term and agreements in pharma biotech and diagnostics
- licensing tech and agreements in pharma biotech and diagnostics
- 2016 data alliance review
-
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Analyze co-development deals in pharma and biotech from 2016 to 2026. Includes financials, deal terms, and access to actual contracts where available.
Learn More -
Distribution Deals in Medical Devices 2016-2026March 2026$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2020-2025October 2015$3,995.00Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Licensing Deals in Biotechnology 2020-2026March 2026$4,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Bioinformatics Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More
